← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 2020-08-14

Drug application

FDA Application #

ANDA205654

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

MESALAMINE

Active ingredients

MESALAMINE

Dosage form

SUPPOSITORY

Route

RECTAL

Marketing status

Prescription

Sponsor

ACTAVIS MID ATLANTIC

Manufacturer

Actavis Pharma, Inc.

First approval

2020-08-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown